Skip to main content

Pathogens in PICU before and during the SARS-CoV-2 pandemic in China: a multicenter retrospective study

Abstract

Background

Nonpharmacological interventions for COVID-19 could reduce the incidence of children hospitalized in pediatric intensive care units (PICU) and the incidence of children with bacterial infections. This study aimed to evaluate changes in the bacterial profile of children in PICU before and during the COVID-19 pandemics.

Methods

This is a retrospective study, involving clinical data of children with positive bacterial cultures admitted to the PICU respectively in 2019 and 2021.

Results

In total 652 children were included in this study. The total number of hospitalized patients and the incidence of bacteria-positive children in 2021 were lower than those in 2019. There were no significant differences in the ratio of Gram-positive bacterial infection, Gram-negative bacteria infection or fungi infection between the two years. The rate of Streptococcus pneumoniae in 2021 was higher than that in 2019(p = 0.127). The incidence of Haemophilus influenzae in hospitalized patients decreased with a downward trend(p = 0.002). The distribution of previous underlying diseases in children admitted to PICU with different outcomes of bacterial infection between the two years were homogeneous (p > 0.05).

Conclusion

After the implementation of COVID-19 isolation, prevention and control measures, the number of hospitalizations and bacterial infections in PICU decreased, which may be due to changes in population’s behavior patterns. Meanwhile, the incidence of Haemophilus influenzae in hospitalized patients decreased with a downward trend.

Peer Review reports

Introduction

COVID-19 caused by SARS-CoV-2 infection broke out in Wuhan, China at the end of 2019. Protective measures such as large-scale control of the movement of population, large-scale disinfection, suspension of school, work and maximum use of masks to cut off the transmission of the coronavirus to the greatest extent were implemented. After applying a series of prevention and control measures, though the spread of the coronavirus has been controlled, it is still prevalent within a certain range.

A United States multi-center study showed that between March 2020 and April 2020, the incidence of acute respiratory illnesses and acute respiratory infection involving respiratory syncytial virus and influenza in children in seven cities continued to decrease. This result may be attributed to timely and sustained isolation measures, which have effectively cut off transmission routes [1]. Children with severe infection admitted to pediatric intensive care unit (PICU) mostly suffer mixed infections of both virus and bacteria. Notably, bacterial infection has been considered as an important complication of influenza pandemic, among which Streptococcus pneumoniae infection is the most common [2].

Moreover, studies have demonstrated that influenza, as a risk factor for bacterial infection, can often lead to secondary bacterial infection of Streptococcus pneumoniae, Staphylococcus aureus or Haemophilus influenzae [3]. In the United States, the number of people vaccinated with pneumococcal vaccine and influenza vaccine decreased significantly during the COVID-19 pandemic [4]. However, taking pneumococcal vaccine as an example, vaccination is an important way to prevent its infection [4, 5]. Although the whole world is struggling to cope with the consequences of the global pandemic associated with severe pneumonia caused by SARS-CoV-2, the existing evidences suggest that bacterial infection is a key factor contributing to severe infection in children. This study aimed to evaluate whether the bacterial pathogens in PICU inpatients in Mainland China changed during the Covid-19 epidemic.

Methods

This is a retrospective study. The data of six representative medical centers in different regions of China were collected, namely: Luoyang Maternal and Child Health Hospital, Henan Province (Central China), The Seventh Medical Center of Chinese PLA General Hospital (North China), Guangdong Provincial People’s Hospital, and The People’s Hospital of Guangxi Zhuang Autonomous Region (South China), Shandong Provincial Hospital (East China), Xi’an Children’s Hospital (West China). Study subjects: the data of children within 48 h of PICU admission from 6 medical centers were evaluated. Inclusion criteria: (1) The patients involved in our research ranged from 29 days to 18 years; (2) Research period in: 2019 and 2021; (3) Children with positive bacterial culture results in the first 48 h of admission; (4) All the children who were admitted to the PICU, including those who were admitted directly to the PICU, and later needed to be admitted to the PICU. The specimens included sputum, tracheal aspirate, nasopharyngeal aspirate, bronchoalveolar lavage fluid, urine, cerebrospinal fluid and blood. Exclusion criteria: (1) Nosocomial infection (The infection occurred within 48 h after into the PICU; The infection directly related to the last hospitalization; A new infection in other parts on the basis of the original infection appeared); (2) The patient was admitted to the PICU after being in the ward for more than 48 h and there was growth in the culture after 48 h of hospitalization; (3) Repeated specimens from the same patient. All laboratory results came from the clinical laboratory management system, data were recorded by a physician on the preprinted case report forms and then collected by another physician with an electronical form. The data directly extracted from the electronical system was validated by two physicians back-to-back. The study was accorded to the approval of the Ethics Committee of Luoyang Maternal and Child Health Hospital, informed consent is not required(KY2022021401.0)(Luoyang; Henan, China). This study was registered at http://www.chictr.org.cn/index.aspx (ChiCTR2200057182).

Statistical analysis

The descriptive variants of all the patient admitted to the PICUs was shown as frequency (percentage) for categorical variables or median (interquartile range) for continuous variables. The statistical analysis was performed with SPSS 24.0 (SPSS Inc., Chicago, USA). The Wilcoxon signed-rank test were used to compare the age, body weight, hospital duration and hospital cost between the two years. The categorical variables including the gender, whether the patients received mechanical ventilation, prognosis and the others were compared by the Cochran-Mantel-Haenszel (CMH) Chi-Square Test. The chi-square test was used to compare the rate of the Streptococcus pneumoniae in Gram positive bacteria and the Haemophilus influenzae in Gram negative bacteria.

Results

In 2019 and 2021, 3700 and 2891 patients were admitted to PICU, including 391 in 2019 and 261 children with positive bacterial culture in 2021. The total number of inpatients and the number of children with positive bacterial culture in 2019 were higher than those in 2021, respectively. A horizontal comparison of the total number of inpatients and the number of children with positive bacterial culture in the same period by month showed that the total number of inpatients in January 2019 was slightly lower than that in 2021, and the monthly data from February to December 2019 were higher than those in 2021 (See Fig. 1).

Fig. 1
figure 1

Monthly distribution of total inpatients and infections in 2019 and 2021

The baseline characteristics of the children with positive bacterial culture in 2019 and 2021 in the 6 medical centers were analyzed without statistically significant differences between the two years: mean age (7 months vs. 8 months, p = 0.119), mean body weight (7.8 kg vs. 8.0 kg, p = 0.094), gender (male 52.7%, female 47.3% vs. male 48.3%, female 51.7%, p = 0.817), the rate of mechanical ventilation (52.7% vs. 48.3%, p = 0.306), length of hospital stay (12d vs. 11d, p = 0.709), hospitalization cost (30.4 thousand yuan vs. 26.4 thousand yuan, p = 0.727), mortality (14.8% vs19.2%, p = 0.178) (see Table 1).

Table 1 Clinical characteristics of the children with positive bacterial culture admitted to PICU in 2019 and 2021

Among the children with positive bacterial culture admitted to the PICUs in 2019 and 2021, the main source of positive results was respiratory tract. The distribution of infection sites showed no statistically significance between the two years (p = 0.467). In our cohort, infection sites include respiratory tract (78.3% vs. 82.8%), blood (11.5% vs. 10.3%), urinary system (2.3% vs. 1.9%), central nervous system (3.1% vs. 1.1%) and lung (4.9% vs. 3.8%) (see Table 2).

Table 2 Distribution of infection sites in children admitted to PICU in 2019 and 2021, n (%)

The rate of Gram-positive bacterial infection (40.4% vs. 42.1%, p = 0.659), Gram-negative bacterial infection (49.6% vs. 52.1%, p = 0.533), and fungi infection (10.0% vs. 5.7%, p = 0.055) in 2019 and 2021 showed no significant differences. The gram-positive bacteria included: Streptococcus pneumoniae, Staphylococcus aureus, Enterococcus faecalis, et al. The gram-negative bacteria included: Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, et al. The fungi included as follows: Candida, Yeast, Aspergillus, Sporoplasma. The two-year comparison found that the rate of Streptococcus pneumoniae in Gram-positive bacteria in 2021 was higher than that in 2019, but without significant differences (23.4% vs. 31.8%, p = 0.127). Notably, among Gram-negative bacteria the rate of Haemophilus influenzae in 2021 was significantly lower than that in 2019 (14.9% vs. 4.4%, p = 0.002) (see Table 3).

Table 3 Changes in Streptococcus pneumoniae and Haemophilus influenzae in 2019 and 2021

Stratified analysis of clinical outcomes and former medical history of children with positive bacterial culture identified no significant differences in the rate of children discharged from hospital with former medical history between 2019 and 2021 (29.4% vs. 32.7%) (p = 0.420). The mortality in children with former medical history in 2021 was higher than that in 2019, though without statistically significant differences (44.0% vs. 37.9%, p = 0.522). The distribution of former medical history in children admitted to PICU with different pathogenic infections and clinical outcomes were homogenous (p > 0.05) (see Table 4).

Table 4 Stratified analysis of clinical outcomes and former medical history of children infected and admitted to PICU in 2019 and 2021

Discussion

Children suspicious of severe bacterial infection in PICU are a frequent challenge for pediatricians, which if not handle with timely appropriate treatment would result in poor prognosis [6]. Bacterial infections in PICU include community acquired infection (CAI) and hospital acquired infection (HAI). This study collected data from patients with community-acquired bacterial infections admitted to PICUs in 6 representative medical centers from different regions of mainland China in 2019 and 2021.

This is a retrospective study based on infection distribution in the PICU of six medical centers and it revealed a decrease in the total number of children’s hospitalizations in 2021 compared to 2019. Studies have reported that quarantine prevention and control measures reduce COVID-19 cases. The timing of prevention and control strategies is strongly associated with the trending decline in the epidemic growth rate of COVID-19 cases [7,8,9]. While quarantine measures are implemented to contain the spread of COVID-19, the incidence of acute respiratory illnesses, respiratory syncytial virus and influenza acute respiratory illnesses in children also decreased [1]. The medical centers involved in this study were under the epidemic prevention and control measures in 2020. Thus, after 2020, the behavioral patterns of the people in 2021 have changed greatly from those in 2019. These conclusions of this study are consistent with previous reports that the number of hospitalizations reduced in 2021 as compared to 2019 might also be attributable to nationwide prevention and control measures, including control of the movement of people, mass disinfection, suspension of classes, work, and maximum use of masks and other protective measures. It should also be taken into consideration that the epidemic prevention and control measures have caused more patients to choose local hospitals for treatment, rather than being referred to higher-level hospitals across regions, which also explains the reduction in the number of hospitalizations.

In the present study, the number of bacterial infections in 2021 was lower than that in 2019. Of note, bacterial infection is an important complication of influenza pandemic [2]. Treatment of viral infection is anticipated to prevent bacterial superinfections, such as oral oseltamivir to anti influenza virus (type A and type B). Although the number of bacterial infections decreased in 2021 as compared with 2019, there was no difference in the distribution of infection sites, and the respiratory system was still the main infection site for bacterial infections in the PICU.

Previous studies have shown that Haemophilus influenzae and Streptococcus pneumoniae are the main pathogens in PICU [10]. Our study found a decrease in the rate of Haemophilus influenzae infections. Haemophilus influenzae, as an opportunistic pathogen, can cause a variety of clinical symptoms including otitis media, epiglottitis, sinusitis, and pneumonia, especially in children, the elderly, and immunocompromised patients. Haemophilus influenzae is mainly transmitted through respiratory droplets from carriers [11]. This result is consistent with the conclusions of previous studies [12, 13]. The various prevention and control measures during the epidemic could possibly cut off the pathogenic infection mainly dependent on the transmission of respiratory droplets [1]. However, a limitation of this study was that we failed to isolate the serotype of Haemophilus influenzae. In addition, unlike Haemophilus influenzae, our study found that the rate of Streptococcus pneumoniae infection in 2021 was higher than that in 2019. Previous studies have shown that for severe community acquired pneumonia patients in intensive care unit, influenza is a risk factor for bacterial infection and Streptococcus pneumoniae is the most common bacterium among the major complications of influenza pandemic [2]. Therefore, theoretically, Streptococcus pneumoniae infection secondary to virus infection should be reduced with declined rate of influenza, which is contrary to the results of this study. We speculate that the increase in Streptococcus pneumoniae infection is possibly relative to the reduced mass movement during the epidemic prevention and control measures, and the decreased vaccination of Streptococcus pneumoniae [3, 4]. In addition, CDC suggested that patients with positive diagnosis of covid-19 should delay routine immunization during the covid-19 pandemic [14]. However, due to the small sample size, no statistical difference between the two years was found. Therefore, a large sample size and long-term observation is necessary for evaluating the changes in Streptococcus pneumoniae infection over the years.

Moreover, we found that the mortality of children with former medical history was 31.9% in 2019 and 44.0% in 2021. Although the rate of hospitalization and bacterial infections in 2021 decreased, the mortality in children with former medical history increased, suggesting that epidemic prevention and control measures may be of some significance for the prevention of infectious diseases in healthy children, but children with previous medical history will need more protection and attention. However, due to the small sample size, there was no statistical difference between the two years, and further research and confirmation are needed for verification.

Limitations

The study has several limitations. Firstly, this study of 3 years span cannot rule out the impact of improved technical improvements and detection rates during these three years. Secondly, this is a multi-center study with diversified distribution of cases provided by different research centers using differed detection methods, and the climate differences between regions may also affect pathogenic microorganisms, the impact of which on the present study have not been explored. Thirdly, disease spectrum and medical levels among medical centers are different, which may have an impact on mortality.

Conclusions

After the implementation of COVID-19 isolation prevention and control measures, we noticed that with changed behavioral patterns in population, the number of PICU admissions and bacterial infections decreased, confirming that isolation and control measures can reduce admissions and bacterial infections in PICU. Meanwhile, the rate of Haemophilus influenzae infection in hospitalized patients demonstrated a downward trend. The rate of Streptococcus pneumoniae increased but without statistically significant differences due to the limited sample size, which requires further investigation.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

SARS-CoV-2:

Severe acute respiratory syndrome

COVID-19:

Coronavirus 2, the cause of coronavirus disease 2019

PICU:

Pediatric intensive care unit

CAI:

Community acquired infection

HAI:

Hospital acquired infection

References

  1. Haddadin Z, Schuster JE, Spieker AJ, Rahman H, Blozinski A, Stewart L, et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective Multicenter Study. Pediatrics. 2021;148(2):e2021051462. https://doi.org/10.1542/peds.2021-051462.

    Article  PubMed  Google Scholar 

  2. MacIntyre CR, Chughtai AA, Barnes M, Ridda I, Seale H, Toms R, et al. The role of Pneumonia and secondary bacterial Infection in fatal and serious outcomes of pandemic Influenza a(H1N1) pdm09. BMC Infect Dis. 2018;18(1):637. https://doi.org/10.1186/s12879-018-3548-0. Published 2018 Dec 7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nair GB, Niederman MS. Updates on community acquired Pneumonia management in the ICU. Pharmacol Ther. 2021;217:107663. https://doi.org/10.1016/j.pharmthera.2020.107663.

    Article  CAS  PubMed  Google Scholar 

  4. Shallal A, Kenney R, Weinmann A. Missed vaccine opportunities for Streptococcus pneumoniae and Influenza in patients admitted during the coronavirus Disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021;42(11):1414–5. https://doi.org/10.1017/ice.2020.1294.

    Article  CAS  PubMed  Google Scholar 

  5. Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae Infections. F1000Res. 2020;9:F1000FacultyRev–338. https://doi.org/10.12688/f1000research.22341.1. Published 2020 May 7.

    Article  CAS  Google Scholar 

  6. Ramilo O, Rodriguez-Fernandez R, Mejias A. Promise and limitations of Procalcitonin to identify bacterial Infections in the Pediatric Intensive Care Unit. J Pediatr. 2016;179:7–9. https://doi.org/10.1016/j.jpeds.2016.09.031.

    Article  PubMed  Google Scholar 

  7. Kanu FA, Smith EE, Offutt-Powell T, Hong R. Declines in SARS-CoV-2 transmission, hospitalizations, and Mortality after implementation of Mitigation Measures- Delaware, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(45):1691–4. https://doi.org/10.15585/mmwr.mm6945e1. Published 2020 Nov 13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hong LX, Lin A, He ZB, Zhao HH, Zhang JG, Zhang C, et al. Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: an epidemiological analysis. Travel Med Infect Dis. 2020;36:101803. https://doi.org/10.1016/j.tmaid.2020.101803.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lasry A, Kidder D, Hast M, Poovey J, Sunshine G, Winglee K, et al. Timing of Community Mitigation and changes in reported COVID-19 and Community mobility - four U.S. Metropolitan Areas, February 26-April 1, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):451–7. https://doi.org/10.15585/mmwr.mm6915e2. Published 2020 Apr 17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Shi T, Chen C, Huang L, Fan H, Lu G, Yang D, et al. Risk factors for mortality from severe community-acquired Pneumonia in hospitalized children transferred to the pediatric intensive care unit. Pediatr Neonatol. 2020;61(6):577–83. https://doi.org/10.1016/j.pedneo.2020.06.005.

    Article  PubMed  Google Scholar 

  11. Epidemiology of Invasive Haemophilus influenzae Serotype a Disease-United States. 2008–2017. Pediatr Infect Dis J. 2021;40(11):1028. https://doi.org/10.1097/INF.0000000000003346.

    Article  Google Scholar 

  12. Cox RA, Slack MP. Clinical and microbiological features of Haemophilus influenzae vulvovaginitis in young girls. J Clin Pathol. 2002;55(12):961–4. https://doi.org/10.1136/jcp.55.12.961.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Vallejo JG, McNeil JC, Hultén KG, Sommer LM, Dunn JJ, Kaplan SL. Invasive Haemophilus influenzae Disease at Texas Children’s Hospital, 2011 to 2018. Pediatr Infect Dis J. 2019;38(9):900–5. https://doi.org/10.1097/INF.0000000000002383.

    Article  PubMed  Google Scholar 

  14. Narducci DM, Diamond AB, Bernhardt DT, Roberts WO. COVID Vaccination in Athletes & Updated Interim Guidance on the Preparticipation Physical examination during the SARS-CoV-2 pandemic. Curr Sports Med Rep. 2021;20(11):608–13. https://doi.org/10.1249/JSR.0000000000000912.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the children and parents who participated in this study.

Funding

This present study was supported by National Key R&D Program of China (NO.2021YFC2701700), Capital’s Funds for Health Improvement and Research (2020-2-5093) and Luoyang City Medical and Health Key Project(2022012 A).

Author information

Authors and Affiliations

Authors

Contributions

JN and CW were responsible for manuscript preparation and manuscript review. contributed equally to the trial. ZF, KF and XH designed the study and reviewed the manuscript, and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.Drafting of the manuscript: JN and YG.Critical revision of the manuscript for important intellectual content and Statistical analysis: ZZ.Acquisition, analysis, or interpretation of data: All authors.Concept and design: SL.

Corresponding authors

Correspondence to Zhichun Feng, Kenan Fang or Xiaoyang Hong.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The trial was conducted in accordance with the 1964 Helsinki Declaration and its later amendments. The study was accorded to the approval of the Ethics Committee of Luoyang Maternal and Child Health Hospital, informed consent is not required(KY2022021401.0)(Luoyang; Henan, China). This study was registered at http://www.chictr.org.cn/index.aspx (ChiCTR2200057182). Informed consent was not required according to the ethics review board.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ni, J., Zhao, Z., Wang, C. et al. Pathogens in PICU before and during the SARS-CoV-2 pandemic in China: a multicenter retrospective study. BMC Infect Dis 23, 710 (2023). https://doi.org/10.1186/s12879-023-08687-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08687-x

Keywords